Latham & Watkins advised Brookfield Asset Management on the transaction, and Wilson Sonsini Goodrich & Rosati advised Divvy Homes. Divvy Homes, a market leader in the...
Brookfield’s $1 Billion Acquisition of Divvy Homes’ Portfolio and Platform
Transcarent’s $621 Million Acquisition of Accolade
Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction, and Cooley advised Accolade. Transcarent, the “One Place for Health and Care,” and Accolade, a leader...
Bolt Medical’s $900 Million of Acquisition of Boston Scientific
Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
Aadi Bioscience’s $849 Million ADC Deal, $100 Million FYARRO Sale and $100 Million PIPE Financing
Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal counsel to Aadi. McDermott Will & Emery LLP is serving as legal counsel to Kaken. Cooley...
IonQ’s Acquisition of Qubitekk
Wilson Sonsini Goodrich & Rosati advised IonQ on the transaction. IonQ (NYSE: IONQ), a leader in quantum computing, announced that it has reached a definitive agreement...
Nokia’s Acquisition of Infinera
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Montrose Environmental’s $128 Million Follow-On Offering
Gibson, Dunn & Crutcher advised Montrose Environmental Group, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised the underwriters. Montrose Environmental Group, Inc. (NYSE:...
Renesas’ $339 Million Acquisition of Transphorm
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
Clearlake Capital Group and Insight Partners’ $4.4 Billion Acquisition of Alteryx
Sidley Austin is advising Clearlake on the transaction, and Willkie Farr & Gallagher is advising Insight, while Wilson Sonsini Goodrich & Rosati and Fenwick & West...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...